Type 2

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/istock-1441541820.jpg?itok=ZcFs-m_6

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/istock-1441541820.jpg?itok=ed2hbAu-

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/istock-1441541820.jpg?itok=EcAM82NE

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/istock-1441541820.jpg?itok=6QdUrIF5

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/istock-1441541820.jpg?itok=SZNxHRZU

FDA Authorizes First Digital Therapy App for Type 2 Diabetes Management

FDA-approved AspyreRx is a&nbsp;digital therapy app for type 2 diabetes that uses&nbsp;CBT to boost&nbsp;wellness and glucose management via smartphone.

Type 1

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/f2baa961-b35f-0391-b6d5-f8a0f0750587.jpg?itok=RYQRyiXa

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/f2baa961-b35f-0391-b6d5-f8a0f0750587.jpg?itok=L00b9PzO

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/f2baa961-b35f-0391-b6d5-f8a0f0750587.jpg?itok=3OsoBHG1

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/f2baa961-b35f-0391-b6d5-f8a0f0750587.jpg?itok=cOmqT5Mn

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/f2baa961-b35f-0391-b6d5-f8a0f0750587.jpg?itok=T-R9-8x3

FDA Approves Farxiga in US for Chronic Heart Failure

Farxiga (dapagliflozin), a SGLT-2 inhibitor, has officially been approved by the FDA&nbsp;to treat all types of heart failure, a common diabetes complication.&nbsp;

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/rybelsus_0.png?itok=gq77jYmf

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/rybelsus_0.png?itok=aMZKpy64

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/rybelsus_0.png?itok=4CjJ4Uk3

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/rybelsus_0.png?itok=IP7bPz72

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/rybelsus_0.png?itok=wt5U9o94

Rybelsus, the First GLP-1 Pill, Approved for Type 2 Diabetes in Europe

Rybelsus, a GLP-1 agonist pill already approved in the US, received positive feedback from the European Medicines Agency (EMA) in January and was just approved on Saturday

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/istock-1411059003.jpg?itok=SuvyXt9o

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/istock-1411059003.jpg?itok=_7m1f5CF

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/istock-1411059003.jpg?itok=ItyUe6xo

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/istock-1411059003.jpg?itok=qX4IGP_E

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/istock-1411059003.jpg?itok=ktOGo8kc

Diabetes Innovation Is Thriving in India

Diabetes is a growing health challenge in India, and with limited resources, innovative solutions are needed to improve management and outcomes.

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/attd-logo_0.png?itok=agyjfpyr

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/attd-logo_0.png?itok=OYL9FIeM

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/attd-logo_0.png?itok=6s9dyd8a

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/attd-logo_0.png?itok=ZTWshZU7

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/attd-logo_0.png?itok=OCztLwn8

Previewing the ATTD 2023 Annual Conference

The diaTribe team is headed to Berlin, Germany, to cover this year’s Advanced Technologies and Treatments for Diabetes (ATTD) conference! Here’s a preview of some sessions we will cover, featuring the latest news in diabetes technology, prevention, managing complications, and more.

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/expert-presenting-new-technology.jpg?itok=RDXyX40k

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/expert-presenting-new-technology.jpg?itok=JSosgKol

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/expert-presenting-new-technology.jpg?itok=68qAEkmr

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/expert-presenting-new-technology.jpg?itok=JpgFh0lg

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/expert-presenting-new-technology.jpg?itok=VCEdE92_

Technology Developments on Display at DiabetesMine Fall Summit

At the DiabetesMine Fall Innovation Summit, medical device manufacturers, patient entrepreneurs, and innovators gathered in San Francisco to display the latest developments in diabetes technology.

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/img_0935.jpg?itok=E8FhjkrE

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/img_0935.jpg?itok=4aCHQZoY

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/img_0935.jpg?itok=Dk8vr_Xu

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/img_0935.jpg?itok=wODb2sim

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/img_0935.jpg?itok=OAZBRwYi

The Renaissance in Diabetes Technology and Therapy

During the European Association for the Study of Diabetes 2022 annual meeting, diaTribe hosted its ninth annual “Solvable Problems in Diabetes” panel discussion, where speakers discussed new therapies for type 2 diabetes, type 1 prevention, the future of diabetes technology, and more.

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/istock-1310511918.jpg?itok=wzX113w6

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/istock-1310511918.jpg?itok=yBn-aQ-a

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/istock-1310511918.jpg?itok=YXDHFC-A

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/istock-1310511918.jpg?itok=LWCMPgUk

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/istock-1310511918.jpg?itok=cUp5XVhg

Type 2 Diabetes Clinical Trials

Advances in blood glucose management, weight loss, and heart health are at the forefront of type 2 diabetes research. Here are some exciting new clinical trials you can join now.

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/istock-1488552777.jpg?itok=P5IWitVA

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/istock-1488552777.jpg?itok=zGiTkjsG

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/istock-1488552777.jpg?itok=M06SVnEZ

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/istock-1488552777.jpg?itok=qizl4xL3

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/istock-1488552777.jpg?itok=yB6X-vDU

Type 1 Diabetes Clinical Trials

Explore groundbreaking type 1 diabetes trials from stem cell therapies to novel drugs that aim to improve health outcomes. Be part of advancing type 1 diabetes treatment today.

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/istock-1212682537.jpg?itok=1AZYP51K

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/istock-1212682537.jpg?itok=s_zBFiuA

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/istock-1212682537.jpg?itok=k_1YuHjD

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/istock-1212682537.jpg?itok=dBFZYN38

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/istock-1212682537.jpg?itok=MEWlGWcW

Join a Trial Researching Semaglutide for Fatty Liver Disease in Type 2 Diabetes and Obesity

Join a study at UC San Diego investigating the potential benefits of the GLP-1 agonist semaglutide in non-alcoholic fatty liver disease (NAFLD).&nbsp;

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/screen-shot-2023-10-05-at-11.36.32-am.png?itok=N5lZ-la9

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/screen-shot-2023-10-05-at-11.36.32-am.png?itok=SgCuVjgZ

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/screen-shot-2023-10-05-at-11.36.32-am.png?itok=V1AzR65X

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/screen-shot-2023-10-05-at-11.36.32-am.png?itok=MbM9vW0B

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/screen-shot-2023-10-05-at-11.36.32-am.png?itok=Qe89xh1u

New Hypoglycemia Tech Could Have Big Benefits for Diabetes Care

Hypo-RESOLVE collaborates internationally to advance hypoglycemia understanding in diabetes. Evolving from a once-understudied concern, its Hypo-METRICS app now captures real-time glucose data, potentially reshaping patient care and therapy. Discover the mission to ease the burden of low blood sugar.

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/istock-1443543154.jpg?itok=suSLEobc

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/istock-1443543154.jpg?itok=a9CLNT3X

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/istock-1443543154.jpg?itok=n0HQuFbJ

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/istock-1443543154.jpg?itok=nWptKjND

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/istock-1443543154.jpg?itok=ysPtX_Ir

Once-Weekly Insulins For Type 1 Diabetes: Latest Research Update

The newest study of once-weekly insulins showed that insulin icodec led to similar reductions in A1C&nbsp;and similar time in range compared to once-daily Tresiba (degludec).&nbsp;&nbsp;

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/logo-easd_0.png?itok=aKLK94OW

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/logo-easd_0.png?itok=9bmWLLNN

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/logo-easd_0.png?itok=lVMdUrzz

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/logo-easd_0.png?itok=mmUus-W9

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/logo-easd_0.png?itok=UBpdGxbg

EASD 2023: Previewing the Latest on Diabetes Medications, Complications, and Technology

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/istock-1369489882.jpg?itok=c7H_eAFc

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/istock-1369489882.jpg?itok=6iQTBqcC

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/istock-1369489882.jpg?itok=EAPaW594

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/istock-1369489882.jpg?itok=DPWAqkEp

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/istock-1369489882.jpg?itok=ATO4S2xp

Beyond Calories – Nutrition Advice from Leading Researchers

Trying to figure out the best nutrition options as a person with diabetes can be a daunting task, and often there are mixed messages about what the best food options are.&nbsp;

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/5c35bd0c-7382-c28d-1b0e-426abbaf2a54.jpg?itok=Qrqs9xUs

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/5c35bd0c-7382-c28d-1b0e-426abbaf2a54.jpg?itok=I144uMIt

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/5c35bd0c-7382-c28d-1b0e-426abbaf2a54.jpg?itok=dqXpmofI

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/5c35bd0c-7382-c28d-1b0e-426abbaf2a54.jpg?itok=bTsjsU94

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/5c35bd0c-7382-c28d-1b0e-426abbaf2a54.jpg?itok=fQu53UQg

New Trial Data Shows Once-Weekly Insulin Improves Time in Range 

Clinical trial results have shown that once-weekly basal insulins are just as effective at reducing A1C as once-daily insulin.&nbsp;

[node:summary] Clinical trial shows once-weekly basal insulins are as safe and effective at maintaining blood sugar levels as once-daily insulin.

Gestational

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/ada-preview-2023.jpeg?itok=mZXB3Zk-

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/ada-preview-2023.jpeg?itok=p96-xbJl

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/ada-preview-2023.jpeg?itok=AFlibWeL

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/ada-preview-2023.jpeg?itok=GoQs3z10

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/ada-preview-2023.jpeg?itok=3G5f3_c_

ADA 2023: Previewing the Latest Diabetes Care Trends and Breakthrough Medications

Join diaTribe at the American Diabetes Association's 83rd scientific conference for insights on future diabetes care, medication, and the latest tech. Plus, explore discussions on time in range, exercise, and pregnancy.

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/d1e2c834-821d-ebaf-c790-eac8a9bc5e3a.jpg?itok=7JQYg0dy

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/d1e2c834-821d-ebaf-c790-eac8a9bc5e3a.jpg?itok=7KPG2Uma

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/d1e2c834-821d-ebaf-c790-eac8a9bc5e3a.jpg?itok=gDba7r-z

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/d1e2c834-821d-ebaf-c790-eac8a9bc5e3a.jpg?itok=m62_uHSc

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/d1e2c834-821d-ebaf-c790-eac8a9bc5e3a.jpg?itok=Orv3yCo8

Using Person-First Language in Scientific Research

The language we use to talk to people with diabetes, and about diabetes in general, can have a real impact. But are scientific and academic publications doing their part to promote the use of person-first language?

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/ec1fae86-8cd0-681d-c419-ebcf27b55d4e.jpg?itok=bLUkQnQA

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/ec1fae86-8cd0-681d-c419-ebcf27b55d4e.jpg?itok=Nb4KvVDO

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/ec1fae86-8cd0-681d-c419-ebcf27b55d4e.jpg?itok=GcXWFv1U

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/ec1fae86-8cd0-681d-c419-ebcf27b55d4e.jpg?itok=mLjqmG-d

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/ec1fae86-8cd0-681d-c419-ebcf27b55d4e.jpg?itok=1YSXi09O

Study Shows Impressive Time in Range Increase for People With Type 2 Diabetes

New study results&nbsp;showed that using an artificial pancreas, or fully closed-loop automated insulin delivery system, improved time spent in a healthy glucose range by eight hours per day for people with type 2 diabetes.

entity.node.canonical

Mission

Who We Are

Programs

Events

Financials & Governance

Donate

News

Type 1 Diabetes

Type 2 Diabetes

Prediabetes

Gestational Diabetes

Diabetes Management

Diabetes Technology

Diabetes Medications

Diabetes Complications